Fresenius Medical Care Renews Leadership with Martin Fischer as CFO for Five Years

Fresenius Medical Care Renews Leadership with Martin Fischer as CFO

Fresenius Medical Care AG, a global leader in providing products and services for individuals with kidney diseases, has made a significant decision regarding its financial leadership. The Supervisory Board has reappointed Martin Fischer as Chief Financial Officer (CFO) for an additional five-year term, extending his service until 2031. This announcement comes as a testament to Fischer's strong leadership and pivotal role in the company's success over the years.

Michael Sen, the Chairman of the Supervisory Board, praised Fischer's consistent leadership style, noting how it has enhanced governance, increased transparency, and bolstered financial discipline within the organization. Sen remarked, "Martin Fischer has demonstrated strong and consistent leadership and has further strengthened Fresenius Medical Care's governance, transparency, and financial discipline." He also emphasized that Fischer's contributions have been crucial in moving the company forward during a period of transformation, making his continued leadership a positive development for the company.

The CEO and Chair of the Management Board, Helen Giza, also expressed her enthusiasm for Fischer's reappointment. Giza stated, "Martin has been a trusted partner in driving performance across the organization. He has played a critical role in strengthening our financial resilience, supporting disciplined capital allocation, and advancing our strategic priorities." Giza looks forward to maintaining a close working relationship with Fischer as they navigate the future together.

In response to the reappointment, Martin Fischer expressed gratitude for the trust placed in him by the Supervisory Board. He noted, "I highly appreciate the Supervisory Board's trust and confidence and look forward to the continued partnership with Helen, the Management Board and our great team at Fresenius Medical Care." Fischer also highlighted the company's clear strategic direction and expressed his excitement about furthering financial discipline and resilience, which are essential for long-term value creation.

Fischer's background is impressive, with a wealth of experience in finance. Before joining Fresenius Medical Care, he served as the Head of Finance for the Diagnostics Division at Siemens Healthineers. He has a degree in Business Informatics from Reutlingen University of Applied Sciences and holds an MBA from Friedrich Alexander University in Nuremberg. Additionally, he completed the prestigious Chief Financial Officer Program at Columbia Business School.

Fresenius Medical Care is not only renowned for its financial management but also for its commitment to improving the lives of patients with renal diseases. Worldwide, approximately 4.5 million patients undergo regular dialysis treatments, and the company's extensive network of 3,539 dialysis clinics provides essential services to around 290,000 patients globally. Moreover, Fresenius is a leading provider of dialysis products, including machines and dialyzers.

The company is publicly traded and listed on both the Frankfurt Stock Exchange (FME) and the New York Stock Exchange (FMS). As it enters this new chapter under Fischer's renewed leadership, Fresenius Medical Care is set to continue making strides in enhancing patient care and innovating within the renal healthcare sector.

In conclusion, Martin Fischer's reappointment as CFO marks a crucial step in Fresenius Medical Care's journey. His track record of effective financial management and his deep understanding of the healthcare landscape will undoubtedly contribute to the company's ongoing success in the years to come.